Patents by Inventor Gerald T. Nepom

Gerald T. Nepom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120321665
    Abstract: A composition for treating an airway inflammatory disease having high molecular weight, crosslinked hyaluronan and at least one aeroallergen is provided. A method of inducing immune tolerance to one or more aeroallergens in a mammalian subject suffering from or at risk of developing an airway inflammatory disease, and a method of treating a human subject suffering from or at risk of developing an airway inflammatory disease or condition of the lungs are also provided.
    Type: Application
    Filed: June 14, 2012
    Publication date: December 20, 2012
    Applicant: BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON
    Inventors: Paul Bollyky, Gerald T. Nepom, Michael G. Kinsella
  • Publication number: 20030176351
    Abstract: The present invention relates to peptides and peptide analogues designed from a human pancreatic islet beta cell autoantigen GAD65. In particular, it relates to antagonistic peptides and peptide analogues that antagonize autoimmune T cell activation in response to GAD65. The invention also relates to methods of using such peptides and peptide analogues for the treatment and prevention of type I diabetes or pre-diabetes.
    Type: Application
    Filed: March 28, 2003
    Publication date: September 18, 2003
    Inventors: Gerald T. Nepom, Susan Masewicz, Barbara S. Nepom
  • Patent number: 5196308
    Abstract: Methods for identifying individuals at increased risk of diabetes are disclosed. The methods disclosed utilize the discovery of the DQw3.2 variant, which identifies a specific allelic polymorphism at a sinle gene locus. One preferred method utilizes a labeled probe to detect the DQw3.2 allele. This method involves estimating the size of the hybridizable DNA fragment generated by a specific restriction endonuclease and therefrom determining the presence of the allele. A second preferred method involves the serologic detection of the DQw3.2 allele. Within this method, immunocomplexes formed between two different MAb's and separate portions of a cell collection are detected and the presence or absence of the allele determined.
    Type: Grant
    Filed: March 13, 1989
    Date of Patent: March 23, 1993
    Assignee: Genetic Systems Corporation
    Inventors: Gerald T. Nepom, Barbara S. Nepom
  • Patent number: 4971902
    Abstract: Oligonucleotide probes for diagnosing predisposition to rheumatoid arthritis, capable of specifically hybridizing with5'-TACGGGGTTGR.sub.1 GAGAGCTT-3'or3'-AR.sub.2 GCCCCAACR.sub.3 CR.sub.2 CR.sub.2 CGAA-5'wherein A is adenine, C is cytosine, G is guanine, T is thymine, R.sub.1 is GT or TG, R.sub.2 is T or uracil, and R.sub.3 is CA or AC. Or, capable of specifically hybridizing with5'-GGAGCAGAR.sub.2 GCGGGCCGCGG-3'or3'-CCR.sub.2 CGR.sub.2 CR.sub.2 R.sub.3 CGCCCGGCGCC-5'wherein R.sub.1 is A or G, R.sub.2 is T or uracil, and R.sub.3 is R.sub.2 or C.
    Type: Grant
    Filed: October 30, 1987
    Date of Patent: November 20, 1990
    Assignee: Virginia Mason Research Center
    Inventor: Gerald T. Nepom